文献速递运动医学关节外科

氨甲环酸在前交叉韧带重建中的应用:系统综述与荟萃分析

Tranexamic Acid in Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis.
PubMed 文献 · Am J Sports Med · 2021-02-25

该系统综述与荟萃分析纳入5项随机对照试验,评估氨甲环酸在前交叉韧带重建中减少关节积血、疼痛及改善功能的效果。结果显示氨甲环酸可减少术后引流量、降低积血分级、改善疼痛评分和关节活动度,且不增加静脉血栓栓塞事件。

要点

  • 氨甲环酸减少前交叉韧带重建术后24小时引流量平均61.5 mL。
  • 氨甲环酸降低积血分级并改善术后6周内疼痛评分。
  • 不增加静脉血栓栓塞事件发生率。

核心结论

  • 静脉使用氨甲环酸可减少前交叉韧带重建术后关节引流量和积血,改善早期疼痛和关节活动度,且不增加并发症或血栓栓塞事件。

研究设计与样本

  • 荟萃分析,纳入5项前瞻性随机对照试验,检索随机对照试验文献。

主要发现

  • 静脉血栓栓塞事件率组间无差异。

关键数值与推荐

  • 静脉给药方案:术前止血带充气前10分钟15 mg/kg负荷,术后可加10 mg/kg/h持续3小时。
  • 关节腔内给药:术中10 mL(100 mg/mL)。
  • 联合给药:止血带充气前10分钟15 mg/kg负荷,止血带放气前10分钟关节腔内3 g。

临床怎么用

  • 前交叉韧带重建围手术期可考虑使用氨甲环酸以减少积血和早期疼痛,改善康复条件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemarthrosis after anterior cruciate ligament (ACL) reconstruction procedures can delay rehabilitation and have toxic effects on the cartilage and synovium. Tranexamic acid is widely used in adult reconstruction procedures; however, its use in ACL reconstruction is a novel topic of study. PURPOSE: To analyze the available literature on hemarthrosis, pain, functional outcomes, and complications after administration of tranexamic acid in ACL reconstruction procedures. STUDY DESIGN: Meta-analysis. METHODS: A literature search was performed to retrieve randomized controlled trials examining the use of tranexamic acid at the time of ACL reconstruction procedures. The studied outcomes included postoperative joint drain output, hemarthrosis grade, visual analog scale scores for pain, range of motion, Lysholm score, postoperative rates of deep venous thrombosis, and pulmonary embolism. Outcomes were pooled to perform a meta-analysis. RESULTS: Five prospective randomized controlled trials met inclusion criteria for analysis. Four studies administered intravenous tranexamic acid in bolus or infusion form before ACL reconstruction, while 2 studies administered tranexamic acid via intra-articular injection. Specifically, tranexamic acid was administered intravenously (preoperative 15-mg/kg bolus 10 minutes before tourniquet inflation with or without 10 mg/kg/h for 3 hours postoperatively) or intra-articularly (10 mL [100 mg/mL] intraoperatively), and 1 study consisted of tranexamic acid administration in combined intravenous and intra-articular forms (15-mg/kg bolus 10 minutes before tourniquet inflation and intra-articular 3 g 10 minutes before tourniquet deflation). Tranexamic acid use in ACL reconstruction cases resulted in a mean reduction of 61.5 mL in postoperative drain output at 24 hours (95% CI, -95.51 to -27.46; P = .0004), lower hemarthrosis grade (P < .00001), improved Lysholm scores, and reduction in visual analog scale scores for pain (-1.96 points; 95% CI, -2.19 to -1.73; P < .00001) extending to postoperative week 6. Range of motion was improved in the immediate postoperative period, and the need for joint aspiration within 2 weeks was reduced (P < .001). There was no difference in venous thromboembolic event rate between the experimental and control groups. CONCLUSION: The use of intravenous tranexamic acid in ACL reconstruction surgery results in reduced joint drain output and hemarthrosis and improved pain scores and range of motion in the initial postoperative period without increased complications or thromboembolic events.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Johns WL, Walley KC, Hammoud S, et al. Tranexamic Acid in Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis. Am J Sports Med. 2021. PMID: 33630652. doi:10.1177/0363546521988943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。